Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Quality Index
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Quality Index of 1.05x as of December 2021. Operating cash flow of $100.71 Million exceeds net income of $96.20 Million, indicating high earnings quality where cash backs reported profits. Explore SNDX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Syndax Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Syndax Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Syndax Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year earnings quality comparison for Syndax Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.17x | $29.13 Million | $24.93 Million | — |